These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22423386)

  • 1. Clinical profiles and long-term outcomes of patients with pancreatic ductal adenocarcinoma and diabetes mellitus.
    Ben Q; Xu M; Jiang Y; Yuan Y; Wang K; Fang J; Li Z
    Diabetes Metab Res Rev; 2012 Feb; 28(2):169-76. PubMed ID: 22423386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution of new-onset diabetes after radical pancreatic resection predicts long-term survival in patients with pancreatic ductal cell adenocarcinoma.
    He XY; Li JF; Yao WY; Yuan YZ
    Ann Surg Oncol; 2013 Nov; 20(12):3809-16. PubMed ID: 23943021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative diabetes mellitus and long-term survival after resection of pancreatic adenocarcinoma.
    Chu CK; Mazo AE; Goodman M; Egnatashvili V; Sarmiento JM; Staley CA; Galloway JR; Adsay NV; Jacobs S; Kooby DA
    Ann Surg Oncol; 2010 Feb; 17(2):502-13. PubMed ID: 19885697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse Oncologic Impact of New-Onset Diabetes Mellitus on Recurrence in Resected Pancreatic Ductal Adenocarcinoma: A Comparison With Long-standing and Non-Diabetes Mellitus Patients.
    Lee S; Hwang HK; Kang CM; Lee WJ
    Pancreas; 2018 Aug; 47(7):816-822. PubMed ID: 29975349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced mean platelet volume levels predict shorter survival in patients with resectable pancreatic ductal adenocarcinoma and type 2 diabetes.
    Yin JB; Li N; Cui MM; Wang X; Wang RT
    BMC Gastroenterol; 2020 May; 20(1):143. PubMed ID: 32393273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New-Onset or Exacerbation of Diabetes Mellitus Is a Clue to the Early Diagnosis of Pancreatic Cancer.
    Takikawa T; Kikuta K; Kume K; Hamada S; Miura S; Yoshida N; Hongo S; Tanaka Y; Matsumoto R; Sano T; Ikeda M; Iseki M; Unno M; Masamune A
    Tohoku J Exp Med; 2020 Dec; 252(4):353-364. PubMed ID: 33342915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of diabetes mellitus on perioperative outcomes after resection for pancreatic adenocarcinoma.
    Chu CK; Mazo AE; Sarmiento JM; Staley CA; Adsay NV; Umpierrez GE; Kooby DA
    J Am Coll Surg; 2010 Apr; 210(4):463-73. PubMed ID: 20347739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
    Shi HJ; Jin C; Fu DL
    World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes associated with pancreatic ductal adenocarcinoma is just diabetes: Results of a prospective observational study in surgical patients.
    Dugnani E; Gandolfi A; Balzano G; Scavini M; Pasquale V; Aleotti F; Liberati D; Di Terlizzi G; Petrella G; Reni M; Doglioni C; Bosi E; Falconi M; Piemonti L
    Pancreatology; 2016; 16(5):844-52. PubMed ID: 27546476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic relevance of preoperative diabetes mellitus and the degree of hyperglycemia on the outcomes of resected pancreatic ductal adenocarcinoma.
    Lee W; Yoon YS; Han HS; Cho JY; Choi Y; Jang JY; Choi H
    J Surg Oncol; 2016 Feb; 113(2):203-8. PubMed ID: 26799261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Association of Recently Diagnosed Diabetes and Long-term Diabetes With Survival in Pancreatic Cancer Patients: A Pooled Analysis.
    Jeon CY; Li D; Cleary S; Stolzenberg-Solomon R; Bosetti C; La Vecchia C; Porta M; Toriola AT; Hung RJ; Kurtz RC; Olson SH
    Pancreas; 2018 Mar; 47(3):314-320. PubMed ID: 29401167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body mass index does not affect the survival of pancreatic cancer patients.
    Jiang QL; Wang CF; Tian YT; Huang H; Zhang SS; Zhao DB; Ma J; Yuan W; Sun YM; Che X; Zhang JW; Chu YM; Zhang YW; Chen YT
    World J Gastroenterol; 2017 Sep; 23(34):6287-6293. PubMed ID: 28974895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Diabetes on Survival after Resection of Pancreatic Adenocarcinoma. A Prospective, Observational Study.
    Balzano G; Dugnani E; Gandolfi A; Scavini M; Pasquale V; Aleotti F; Liberati D; Di Terlizzi G; Petrella G; Reni M; Doglioni C; Bosi E; Falconi M; Piemonti L
    PLoS One; 2016; 11(11):e0166008. PubMed ID: 27814399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-L1 expression in pancreatic ductal adenocarcinoma is a poor prognostic factor in patients with high CD8
    Yamaki S; Yanagimoto H; Tsuta K; Ryota H; Kon M
    Int J Clin Oncol; 2017 Aug; 22(4):726-733. PubMed ID: 28314962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved long-term outcomes after resection of pancreatic adenocarcinoma: a comparison between two time periods.
    Serrano PE; Cleary SP; Dhani N; Kim PT; Greig PD; Leung K; Moulton CA; Gallinger S; Wei AC
    Ann Surg Oncol; 2015 Apr; 22(4):1160-7. PubMed ID: 25348784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic volume is one of the independent prognostic factors for resectable pancreatic ductal adenocarcinomas.
    Fukumoto T; Watanabe T; Hirai I; Kimura W
    J Hepatobiliary Pancreat Sci; 2016 Aug; 23(8):472-9. PubMed ID: 27246905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of preoperative diabetes on long-term survival after curative resection of pancreatic adenocarcinoma: a systematic review and meta-analysis.
    Walter U; Kohlert T; Rahbari NN; Weitz J; Welsch T
    Ann Surg Oncol; 2014 Apr; 21(4):1082-9. PubMed ID: 24322532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower plasma levels of glucose-dependent insulinotropic peptide (GIP) and pancreatic polypeptide (PP) in patients with ductal adenocarcinoma of the pancreas and their relation to the presence of impaired glucoregulation and weight loss.
    Škrha J; Bušek P; Uhrová J; Hrabal P; Kmochová K; Laclav M; Bunganič B; Frič P
    Pancreatology; 2017; 17(1):89-94. PubMed ID: 28027898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after curative intent surgical resection.
    Kim NH; Kim HJ
    Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):450-455. PubMed ID: 30237091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes mellitus does not impact on clinically relevant pancreatic fistula after partial pancreatic resection for ductal adenocarcinoma.
    Malleo G; Mazzarella F; Malpaga A; Marchegiani G; Salvia R; Bassi C; Butturini G
    Surgery; 2013 May; 153(5):641-50. PubMed ID: 23276391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.